Abstract:Pharmaceuticals are of concern to our planet and health as they can accumulate in the environment. The impact of these biologically active compounds on ecosystems is hard to predict, and information on their biodegradation is necessary to establish sound risk assessment. Microbial communities are promising candidates for the biodegradation of pharmaceuticals such as ibuprofen, but little is known yet about their degradation capacity of multiple micropollutants at higher concentrations (100 mg/L). In this work, microbial communities were cultivated in lab-scale membrane bioreactors (MBRs) exposed to increasing concentrations of a mixture of six micropollutants (ibuprofen, diclofenac, enalapril, caffeine, atenolol, paracetamol). Key players of biodegradation were identified using a combinatorial approach of 16S rRNA sequencing and analytics. Microbial community structure changed with increasing pharmaceutical intake (from 1 to 100 mg/L) and reached a steady-state during incubation for 7 weeks on 100 mg/L. HPLC analysis revealed a fluctuating but significant degradation (30-100%) of five pollutants (caffeine, paracetamol, ibuprofen, atenolol, enalapril) by an established and stable microbial community mainly composed of Achromobacter, Cupriavidus, Pseudomonas and Leucobacter. By using the microbial community from MBR1 as inoculum for further batch culture experiments on single micropollutants (400 mg/L substrate, respectively), different active microbial consortia were obtained for each single micropollutant. Microbial genera potentially responsible for degradation of the respective micropollutant were identified, i.e. Pseudomonas sp. and Sphingobacterium sp. for ibuprofen, caffeine and paracetamol, Sphingomonas sp. for atenolol and Klebsiella sp. for enalapril. Our study demonstrates the feasibility of cultivating stable microbial communities capable of degrading simultaneously a mixture of highly concentrated pharmaceuticals in lab-scale MBRs and the identification of microbial genera potentially responsible for the degradation of specific pollutants. KEY POINTS: • Multiple pharmaceuticals were removed by stable microbial communities. • Microbial key players of five main pharmaceuticals were identified.

Sorption and biodegradation of pharmaceuticals in aerobic activated sludge system: A combined experimental and theoretical mechanistic study

Integrated photocatalysis and moving bed biofilm reactor (MBBR) for treating conventional and emerging organic pollutants from synthetic wastewater: Performances and microbial community responses

Fabrication of an intimately coupled photocatalysis and biofilm system for removing sulfamethoxazole from wastewater: Effectiveness, degradation pathway and microbial community analysis

Understanding the role of bacterial cellular adsorption, accumulation and bioavailability regulation by biosurfactant in affecting biodegradation efficacy of polybrominated diphenyl ethers

Biotransformation and Adsorption of Pharmaceutical and Personal Care Products by Activated Sludge after Correcting Matrix Effects.

Primary culture of rat thymic non-lymphoid cells: influence of culture time on the expression of macrophage differentiation antigens defined by monoclonal antibodies.

Combined use of strictly anaerobic MBBR and aerobic MBR for municipal wastewater treatment and removal of pharmaceuticals

Insights into removal of sulfonamides in anaerobic activated sludge system: Mechanisms, degradation pathways and stress responses

Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme

Intimately coupled photocatalysis and biodegradation for effective simultaneous removal of sulfamethoxazole and COD from synthetic domestic wastewater

Study on the removal characteristics and degradation pathways of highly toxic and refractory organic pollutants in real pharmaceutical factory wastewater treated by a pilot-scale integrated process

Immune activation by histones: Plusses and minuses in inflammation

The authentic sequence of rotavirus SA11 nonstructural protein NSP4.

Biodegradation behaviour of pharmaceutical compounds and selected metabolites in activated sludge. A forecasting decision system approach

Influence of organic loading rate on ciprofloxacin and sulfamethoxazole biodegradation in anaerobic fixed bed biofilm reactors

What price reproductive potential?

Removal of sulfamethoxazole and trimethoprim from reclaimed water and the biodegradation mechanism

Mitral valve rheumatic multiple fenestrations: usefulness of 3D real-time echocardiography.

Biodegradation and Adsorption of Antibiotics in the Activated Sludge Process.

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

Bio-degraded of sulfamethoxazole by microbial consortia without addition nutrients: Mineralization, nitrogen removal, and proteomic characterization